Nutrition21 Welcomes Patent & Intellectual Property Attorney, Sara O'Brien
Nutrition 21, LLC, a leading developer, and marketer of efficacious, high-value, patented nutritional products whose health benefits are substantiated with clinical research, announced today that Sara O’Brien has joined as General Counsel of JDS Therapeutics, and its wholly-owned subsidiary Nutrition 21.Ms. O’Brien joins Nutrition 21 after working in the Intellectual Property departments of Willkie Farr & Gallagher and Ropes & Gray, where she most recently specialized in patent litigation. Sara’s private practice included…
Nitrosigine®, Velositol®, nooLVL®, Lustriva™, Chromax®, Zinmax®, and their associated logos are registered trademarks of Nutrition21, LLC. All third party trademarks are the property of their respective owners. Nutrition21, LLC's products are protected by a number of patents including, but not limited to: US Patent Nos. 6,809,115; 6,803,456; 7,576,132; 8,062,677; 8,933,022; 9,005,637; 9,028,879; 9,119,835; 9,421,170; 9,597,404; 9,675,702; 10,183,049; 10,245,325; and 10,363,222.
These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.